Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Edge Therapeutics, Inc.
Industry Biotechnology
Founded 2009
Headquarters Berkeley Heights, NJ, U.S.
Key people

Brian Leuthner (President & CEO)

R Loch Macdonald (Chief Scientific Officer)
Website http://www.edgetherapeutics.com

Brian Leuthner (President & CEO)

Edge Therapeutics, Inc. is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions. EG-1962, Edge's lead product candidate, has the potential to fundamentally improve patient outcomes and transform the management of aneurysmal subarachnoid hemorrhage, or aSAH, which is bleeding around the brain due to a ruptured brain aneurysm. EG-1964, Edge's second product candidate, is being evaluated as a potential prophylactic treatment in the management of chronic subdural hematoma, to prevent recurrent bleeding on the surface of the brain.

EG-1962 and EG-1964 both utilize Edge’s proprietary, programmable, biodegradable polymer-based development platform, known as Precisa™. The Precisa platform allows Edge to create therapeutics capable of delivering medicines directly to the site of injury, providing a novel delivery mechanism that enables targeted and sustained drug exposure while potentially avoiding the systemic, dose-limiting side effects often associated with current standards of care.

Investment goal date:
Dividends reinvested
Edge Therapeutics, Inc. EDGE report
Period
Date
Adjusted Actuals EPS
GAAP EPS
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BlackRock Fund Advisors
517087
BlackRock Inc.
735332
BlackRock Institutional Trust Company, N.A.
146449
EAGLE ASSET MANAGEMENT INC
899968
FRANKLIN RESOURCES INC
2633023
GEODE CAPITAL MANAGEMENT, LLC
172646
JANUS CAPITAL MANAGEMENT LLC
2115566
Longwood Capital Partners LLC
1351516
New Leaf Venture Partners, L.L.C.
2344868
NORTHERN TRUST CORP
177433
Opaleye Management Inc.
280000
SPHERA FUNDS MANAGEMENT LTD.
150000
STATE STREET CORP
238443
Vanguard Group, Inc
700003
VHCP Management, LLC
135000
Major Shareholders
Name Relationship
Total Shares
Holding stocks